TG Therapeutics Inc (TGTX)
30.84
-4.06
(-11.62%)
USD |
NASDAQ |
Nov 14, 16:00
31.00
+0.16
(+0.50%)
After-Hours: 20:00
TG Therapeutics Gross Profit (Annual): 219.53M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 219.53M |
December 31, 2022 | 2.52M |
December 31, 2021 | 5.899M |
December 31, 2020 | 0.152M |
December 31, 2019 | 0.152M |
December 31, 2018 | |
December 31, 2017 | |
December 31, 2016 | |
December 31, 2015 | |
December 31, 2014 | |
December 31, 2013 | |
December 31, 2012 | |
December 31, 2011 | |
December 31, 2010 | 0.00 |
Date | Value |
---|---|
December 31, 2009 | 0.00 |
December 31, 2008 | 0.00 |
December 31, 2007 | |
December 31, 2006 | |
December 31, 2005 | |
December 31, 2004 | |
December 31, 2003 | |
December 31, 2002 | |
December 31, 2001 | 0.6294M |
December 31, 2000 | 1.300M |
December 31, 1999 | 0.40M |
December 31, 1998 | 2.70M |
December 31, 1997 | 0.20M |
December 31, 1996 | -1.00M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
0.152M
Minimum
2019
219.53M
Maximum
2023
45.65M
Average
2.52M
Median
2022
Gross Profit (Annual) Benchmarks
ADMA Biologics Inc | 88.94M |
Varex Imaging Corp | 290.30M |
Rhythm Pharmaceuticals Inc | 68.13M |
Inspire Medical Systems Inc | 528.22M |
Precision BioSciences Inc | -- |